Perceptive Advisors as of Sept. 30, 2011
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 57 positions in its portfolio as reported in the September 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 12.2 | $26M | 415k | 61.91 | |
Neurocrine Biosciences (NBIX) | 7.5 | $16M | 2.6M | 5.98 | |
Aegerion Pharmaceuticals | 7.4 | $16M | 1.2M | 12.67 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 6.3 | $13M | 300k | 44.46 | |
Ariad Pharmaceuticals | 5.8 | $12M | 1.4M | 8.79 | |
Endo Pharmaceuticals | 4.2 | $9.0M | 320k | 27.99 | |
Endocyte | 4.2 | $8.9M | 843k | 10.60 | |
Repros Therapeutics | 4.1 | $8.6M | 2.3M | 3.73 | |
Impax Laboratories | 3.8 | $8.0M | 446k | 17.91 | |
Capital Senior Living Corporation | 3.0 | $6.3M | 1.0M | 6.17 | |
Trimeris | 2.8 | $5.9M | 2.3M | 2.52 | |
Amgen | 2.8 | $5.8M | 106k | 54.96 | |
Avi Biopharma | 2.8 | $5.8M | 5.2M | 1.12 | |
Shire | 2.7 | $5.8M | 61k | 93.93 | |
Pharmacyclics | 2.4 | $5.1M | 432k | 11.83 | |
Abbott Laboratories | 2.2 | $4.6M | 90k | 51.14 | |
Johnson & Johnson (JNJ) | 2.1 | $4.5M | 70k | 63.69 | |
NPS Pharmaceuticals | 2.1 | $4.5M | 685k | 6.51 | |
Allergan Inc Com Stk | 2.1 | $4.5M | 54k | 82.38 | |
Express Scripts | 2.0 | $4.3M | 116k | 37.07 | |
Pharmasset | 1.9 | $4.1M | 50k | 82.38 | |
Human Genome Sciences | 1.3 | $2.8M | 220k | 12.69 | |
Athersys | 1.3 | $2.6M | 1.5M | 1.76 | |
Examworks | 1.1 | $2.4M | 232k | 10.18 | |
Optimer Pharmaceuticals | 1.0 | $2.1M | 150k | 13.84 | |
Immunomedics | 0.9 | $2.0M | 612k | 3.20 | |
D Alexion Pharmaceutic Als Inc C Common Stock 0 | 0.9 | $1.9M | 30k | 64.07 | |
Trius Therapeutics | 0.9 | $1.9M | 301k | 6.30 | |
Hologic (HOLX) | 0.8 | $1.8M | 118k | 15.21 | |
Response Genetics (RGDXQ) | 0.8 | $1.7M | 912k | 1.90 | |
Neptune Technologies Bioreso | 0.8 | $1.7M | 654k | 2.61 | |
Bristol Myers Squibb (BMY) | 0.7 | $1.6M | 50k | 31.38 | |
Onyx Pharmaceuticals | 0.7 | $1.5M | 50k | 30.02 | |
Exelixis (EXEL) | 0.7 | $1.4M | 250k | 5.46 | |
Trinity Biotech | 0.5 | $1.1M | 119k | 9.16 | |
Affymax (AFFY) | 0.4 | $897k | 200k | 4.48 | |
Neostem (NBS) | 0.4 | $827k | 1.3M | 0.65 | |
Solta Medical | 0.3 | $729k | 583k | 1.25 | |
BioSante Pharmaceuticals | 0.3 | $684k | 300k | 2.28 | |
BioDelivery Sciences International | 0.3 | $656k | 602k | 1.09 | |
Dynavax Technologies Corporation | 0.2 | $428k | 230k | 1.86 | |
SIGA Technologies (SIGA) | 0.2 | $327k | 100k | 3.27 | |
iShares Russell 2000 Index (IWM) | 0.1 | $322k | 5.0k | 64.40 | |
Somaxon Pharmaceuticals | 0.1 | $268k | 308k | 0.87 | |
LeMaitre Vascular (LMAT) | 0.1 | $254k | 41k | 6.21 | |
Array BioPharma | 0.1 | $195k | 100k | 1.95 | |
NxStage Medical | 0.1 | $156k | 7.5k | 20.80 | |
INC Ventrus Biosciences | 0.1 | $110k | 12k | 9.02 | |
Allos Therapeutics | 0.0 | $92k | 50k | 1.84 | |
Epocrates | 0.0 | $77k | 8.5k | 9.06 | |
Abiomed Inc Com Stk | 0.0 | $55k | 5.0k | 11.00 | |
Sanofi Aventis Wi Conval Rt | 0.0 | $53k | 50k | 1.06 | |
Uroplasty | 0.0 | $49k | 10k | 4.90 | |
Senesco Technologies | 0.0 | $51k | 223k | 0.23 | |
Auxilium Pharmaceuticals | 0.0 | $15k | 1.0k | 15.00 | |
TranS1 (TSON) | 0.0 | $7.0k | 2.3k | 3.01 | |
Combimatrix Corporation *w exp 05/01/201 | 0.0 | $10k | 50k | 0.20 |